Skip Navigation LinksHome > February 2014 - Volume 21 - Issue 1 > Update on endocrine and metabolic therapy-related late effec...
Text sizing:
A
A
A
Current Opinion in Endocrinology, Diabetes & Obesity:
doi: 10.1097/MED.0000000000000029
GROWTH AND DEVELOPMENT: Edited by Lynne L. Levitsky

Update on endocrine and metabolic therapy-related late effects observed in survivors of childhood neoplasia

Chemaitilly, Wassima,b; Hudson, Melissa M.b,c

Collapse Box

Abstract

Purpose of review

To provide a summary of the most recent research pertaining to the endocrine and metabolic complications observed in childhood cancer survivors.

Recent findings

Data on prevalence and risk associations are increasingly available from large cohorts of childhood cancer survivors. New directions in research include novel risk-prediction strategies and the study of genetic predisposition.

Summary

Endocrine complications are observed in more than 50% of adult childhood cancer survivors. Some continue to develop decades following cancer treatment exposures. The present review provides a summary of the most recent outcomes research pertaining to growth, thyroid, gonadal–reproductive, bone and body composition with emphasis on new directions and challenges in each area.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.